ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

0
Player Avatar bdescent (68.81) Submitted: 8/15/2012 6:36:59 PM : Outperform Start Price: $25.13 VPHM Score: -11.08

Trending nicely.

Featured Broker Partners


Advertisement